Copyright
©The Author(s) 2017.
World J Radiol. Sep 28, 2017; 9(9): 350-358
Published online Sep 28, 2017. doi: 10.4329/wjr.v9.i9.350
Published online Sep 28, 2017. doi: 10.4329/wjr.v9.i9.350
Mean SUVmax | MeanSUVmean | |
Sectorial analysis | ||
MRI - normal prostatic sectors | 3.02 | 1.74 |
MRI - suspicious prostatic sectors | 3.1 | 1.89 |
Histopathology - benign prostatic lobe | 2.86 | 1.79 |
Histopathology - malignant prostatic lobe | 3.13 | 1.82 |
Case-control analysis | ||
Age-matched controls | 3.09 | 1.83 |
Cases with prostate cancer | 3.26 | 1.81 |
Subgroup analysis | ||
Biopsy not performed | 4.95 | 1.91 |
Benign disease and high-grade PIN | 5.85 | 2.86 |
Low-grade prostate cancer (Gleason ≤ 3 + 4) | 3.2 | 1.83 |
High-grade prostate cancer (Gleason score ≥ 4 + 3) | 3.35 | 1.78 |
- Citation: Chetan MR, Barrett T, Gallagher FA. Clinical significance of prostate 18F-labelled fluorodeoxyglucose uptake on positron emission tomography/computed tomography: A five-year review. World J Radiol 2017; 9(9): 350-358
- URL: https://www.wjgnet.com/1949-8470/full/v9/i9/350.htm
- DOI: https://dx.doi.org/10.4329/wjr.v9.i9.350